Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

42.00
-0.2593-0.61%
Post-market: 42.000.00000.00%19:30 EDT
Volume:325.77K
Turnover:13.70M
Market Cap:1.06B
PE:- -
High:42.13
Open:42.00
Low:41.83
Close:42.26
52wk High:42.87
52wk Low:27.30
Shares:25.15M
Float Shares:25.15M
Volume Ratio:3.47
T/O Rate:1.30%
Dividend:0.42
Dividend Rate:1.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Johnson & Johnson Report Flags Rise of “surgical Intelligence” as Next Digital Surgery Inflection Point

Reuters
·
Aug 18

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18

Lytix Biopharma Names Timothy Herpin Chief Business Officer

Reuters
·
Aug 18

Basilea Publishes Investor Presentation on Anti-Infectives Strategy and Pipeline Progress

Reuters
·
Aug 18

Perrigo Co. PLC Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Aug 18

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

Eli Lilly Canada: Disagrees with Characterizations in Canada Revenue Agency’s Application; Will Respond Formally Through Court Process in Due Course

THOMSON REUTERS
·
Aug 17

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase III Clinical Trials for Brenipatide in China

Reuters
·
Aug 17

The Mediterranean Diet is the Best One Out There. Here's Why Americans Struggle with It.

Dow Jones
·
Aug 17

Eli Lilly Launches New Phase III Trial in China for Its Once-Daily Depression Candidate

Stock News
·
Aug 17

J&J Receives U.S. FDA 510(k) Clearance for Monarch Quest 3

Reuters
·
Aug 17

Johnson & Johnson Announces Monarch™ Quest 3, Advancing the Latest in Robotically-Assisted Bronchoscopy

THOMSON REUTERS
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

Merck upgraded to Outperform from Neutral at Daiwa

TIPRANKS
·
Aug 17